TSX: IGX
TSX: IGX

VevaDermTM

 

VevaDerm Official logo

IntelGenx has a Long History in Transdermal Development & Manufacturing

 

 

Group 69

Fully integrated solution provider for Drug-In-Adhesive transdermal products

Group 67

Experience developing transdermal products across multiple therapeutic areas, including cardiovascular, CNS and hormonal products

 

 

Transdermal Technology Value Proposition

Addressing Chronic Diseases and Older Populations Needs

Growth in chronic disease prevalence and an increasing geriatric population are resulting in an increased need for transdermal medicines.

 

 

 minimally invasive and painless delivery solution


 Group 76 

Reduced frequency of dosing 


 Reduced adverse effects


 Prolonged duration of action


 

 

Drug-In-Adhesive Patch
Versatile, Controlled and Predictable Drug Delivery System

 

Group 70

 

Group 77  Controlled & predictable drug delivery through the skin

Group 77  High loading drug capacity

Group 77  Single or multilayers design

Group 69

 

Backing Solvent-casted foil
Drug-in-adhesive Dispersed drug, polymers, plasticizers,
penetration enhancers, etc.
Release liner  Siliconized or fluoro-siliconized polyester film
 

Transdermal Development & Manufacturing
Integrated Offering

  • Significant formulation development experience focused on drug-inadhesive patches
  • Single and multilayer patch capabilities
  • Aqueous and solvent coating
  • Pilot and commercial-scale manufacturing and packaging equipment

2
Ralph Yeung LAS8697 1